Pharmacists in Smelterville, ID Accepting Medicare
3 Pharmacists found. Showing 1 - 3
 Mr. Lloyd Rauenhorst Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 504 Commerce Dr, Smelterville, ID 83868 Phone: 208-783-2739 Fax: 208-783-2825 |
Mr. Jeffrey Boyd Arthurs, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 583 Commerce Dr, Smelterville, ID 83868 Phone: 208-783-2739 Fax: 208-783-2925 |
Dr. Isaac Jisung Lee Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 583 Commerce Drive, Smelterville, ID 83868 Phone: 208-783-2739 |
News Archive
SIGA completes fourth human clinical trial of ST-246 smallpox antiviral drug candidate
SIGA Technologies, Inc., a company specializing in the development of pharmaceutical agents to combat bio-warfare pathogens, announced today the successful completion of its fourth human clinical trial, supporting the safety and tolerability of the anticipated clinical dose of ST-246®, SIGA's lead smallpox antiviral drug candidate.
Early-term births associated with higher neonatal morbidity, shows study
Early-term births (37 to 38 weeks gestation) are associated with higher neonatal morbidity (illness) and with more neonatal intensive care unit (NICU) or neonatology service admissions than term births (39 to 41 weeks gestation), according to a study by Shaon Sengupta, M.D., M.P.H., now of the Children's Hospital of Philadelphia and formerly of the University at Buffalo, N.Y., and colleagues.
APP Pharmaceuticals to commence marketing of Oxaliplatin Injection in U.S
Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that APP Pharmaceuticals will immediately begin marketing Oxaliplatin Injection (liquid) in the U.S. The U.S. Food and Drug Administration granted approval to market Oxaliplatin Injection in two dosage strengths to Fresenius Kabi Oncology Limited. APP Pharmaceuticals and Fresenius Kabi Oncology Limited are members of the Fresenius Kabi Group of companies. APP currently markets the lyophilized product, Oxaliplatin for Injection, 50 mg and 100 mg.
Also in Global Health news: Drug trafficking in Kenya; violence in S. Sudan; Uganda bill; sleeping sickness
Drug trafficking and use are fueling the spread of HIV/AIDS in Kenya, according to a recent report by the U.N. Security Council, the Nation reports. "A statement from the council's Presidency currently … states that Afghan heroin was being imported, causing a dramatic increase in heroin addiction and spreading HIV/AIDS in the slums of Nairobi and Mombasa, Kenya's two main cities," the newspaper writes.
Hasting center publishes new articles on Federal Right to Try, Citizen Science and Gamification
Many patients with terminal or serious illness who have exhausted their treatment options want access to experimental therapies they hope will help them.
› Verified 5 days ago